Submitted by Anonymous (not verified) on 27 May 2026 - 14:04
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 1, Status: Authorised